Clinical Trials
14 trialsNCT03258554 2026-06-02
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
Phase 2/3 Completed
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05561920 2026-03-31
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
Osijek University Hospital
Completed
NCT02589938 2026-02-27
ACUPUNCTURE
Wake Forest University Health Sciences
Phase NA Completed
NCT03082534 2026-01-28
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
University of California, San Diego
Phase 2 Completed
NCT00576134 2025-12-22
The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement
University Hospital, Strasbourg, France
Phase 1 Completed
NCT05406024 2025-12-11
FAISA-CORPPS
University Hospital, Lille
Completed
NCT07241611 2025-11-21
Role of Cervical Fascia Flap in Decreasing the Incidence of Pharyngocutaneous Fistula After Total Laryngectomy
Mansoura University
Phase NA Completed
NCT02918955 2025-11-20
UPFRONT-NECK
Insel Gruppe AG, University Hospital Bern
Phase 3 Completed
NCT01257633 2025-11-17
Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance
Centre Hospitalier Universitaire de Nīmes
Completed
NCT06129487 2025-11-14
Evaluations of Alcohol Warning Labels
University of Connecticut
Phase NA Completed
NCT02586207 2025-10-07
Pembrolizumab in Combination With CRT for LA-SCCHN
Sanford Health
Phase 1 Completed
NCT05497947 2025-09-08
SOAL-VF
Centre Hospitalier de Valence
Completed
NCT06852651 2025-07-16
The Efficacy of Superficial Cervical Block Application in Postoperative Analgesia Management in Patients Undergoing Total Laryngectomy and Bilateral Neck Dissection
Başakşehir Çam & Sakura City Hospital
Phase NA Completed